Apellis Pharmaceuticals, Inc. (APLS)
41.03
0.00 (0.00%)
USD |
NASDAQ |
May 15, 16:00
Apellis Pharmaceuticals EPS Diluted (Quarterly) : 0.142 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Eli Lilly & Co. | 8.255 |
| Agios Pharmaceuticals, Inc. | -1.686 |
| Spyre Therapeutics, Inc. | -0.8785 |
| Scholar Rock Holding Corp. | -0.829 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 18.66M |
| Revenue (Quarterly) | 268.30M |
| Total Expenses (Quarterly) | 249.64M |
| Enterprise Value | 5.322B |
| Gross Profit Margin (Quarterly) | 84.78% |
| Profit Margin (Quarterly) | 6.95% |
| Earnings Yield | 2.44% |
| Operating Earnings Yield | 3.13% |
| Normalized Earnings Yield | 2.439 |